October, 2007: Perlegen to Develop a Breast Cancer Test

Perlegen Sciences plans to commercialize a new diagnostic test of breast cancer susceptibility. The markers were identified through research conducted by the University of Cambridge, Cancer Research Technology (CRT), and Cancer Research U.K. The study, published in the June issue of Nature, identified novel breast cancer susceptibility markers that are present in approximately 20% of U.K. breast cancer cases.